HCLTECH.NS · NSI · Technology
HCL Technologies Limited
Also onConsensus Drift
Implied value per share
INR 230553.13
Market price
INR 1249.30
Implied upside
+18354.6%
5-year forecast · Perpetuity growth terminal value · Mid-year discounting · Base case · USD model at 95.8630
Value Per Share
Same forecast, different terminal treatment. Percentages vs price.
Forecast Cashflows
Reporting currency (USD). Outflows negative.
| Line | FY27 | FY28 | FY29 | FY30 | FY31 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | USD 1414.1bn | USD 1536.5bn | USD 1669.4bn | USD 1813.9bn | USD 1970.9bn | +8.7% |
| EBIT | USD 449.2bn | USD 488.0bn | USD 530.3bn | USD 576.2bn | USD 626.0bn | +8.7% |
| NOPAT | USD 337.5bn | USD 366.7bn | USD 398.4bn | USD 432.9bn | USD 470.4bn | +8.7% |
| Add depreciation & amortisation | USD 52.0bn | USD 56.5bn | USD 61.4bn | USD 66.7bn | USD 72.5bn | +8.7% |
| Less capital expenditure | USD -34.6bn | USD -37.6bn | USD -40.9bn | USD -44.4bn | USD -48.3bn | +8.7% |
| Less increase in working capital | USD 15.9bn | USD 17.3bn | USD 18.8bn | USD 20.4bn | USD 22.2bn | -8.7% |
| Free cashflow to firm | USD 370.8bn | USD 402.9bn | USD 437.7bn | USD 475.6bn | USD 516.8bn | +8.7% |
| Discount factor | 0.9561 | 0.8739 | 0.7988 | 0.7301 | 0.6674 | - |
| Present value | USD 354.5bn | USD 352.1bn | USD 349.7bn | USD 347.3bn | USD 344.9bn | -0.7% |
| Present Value Of The Forecast | USD 1748.4bn | |||||
Discount Rate
Source shown per component. All overridable above.
| Risk-free rate | 6.80% | INR assumption - no free live source available for this market (assumption) |
| Equity risk premium | 8.00% | Market assumption |
| Beta | 0.331 | Reported 0.001, pulled toward 1.0 (Blume) |
| Cost of equity | 9.45% | Risk-free + beta x equity risk premium |
| Cost of debt | 8.80% | Implied cost of debt of 15.1% is not a credible funding cost, so risk-free + 2bp is assumed instead. Interest expense and reported debt are measuring different things - common for banks, whose interest expense includes deposits that total debt excludes. |
| Market capitalisation | USD 3380.3bn | 98.5% of capital |
| Total debt | USD 52.1bn | 1.5% of capital, book value as a proxy |
| Tax rate | 24.9% | Effective, capped at statutory |
| WACC | 9.40% | E/V x Re + D/V x Rd x (1 - t) |
Terminal Value
Perpetuity growth is intrinsic. The exit multiple defaults to the company's current EV/EBITDA, so it answers a different question - what the shares are worth if today's rating holds and EBITDA grows as forecast.
Perpetuity growth at 2.50%
72% of EV
- Forecast FCFF, final year
- USD 516.8bn
- Capex at depreciation, working capital in reinvestment
- USD 488.6bn
- Less reinvestment at g/ROIC (6.6% of NOPAT)
- USD -32.4bn
- Capitalised
- USD 456.1bn
- ROIC (reported)
- 37.7%
- Terminal value, undiscounted
- USD 6773.8bn
- Terminal value, discounted
- USD 4520.7bn
- Enterprise value
- USD 6269.2bn
- Less net debt
- USD -254.0bn
- Equity value
- USD 6523.2bn
Exit at 6.9x EBITDA
65% of EV
- Terminal value, undiscounted
- USD 4834.4bn
- Terminal value, discounted
- USD 3226.4bn
- Enterprise value
- USD 4974.8bn
- Less net debt
- USD -254.0bn
- Equity value
- USD 5228.8bn
Spread between methods: 22%.
Sensitivity
Value per share (USD) by discount rate and long-run growth.
| Long-run growth | |||||
|---|---|---|---|---|---|
| Discount rate | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
| 7.40% | 2925.63 | 3104.12 | 3318.67 | 3581.56 | 3911.37 |
| 8.40% | 2522.26 | 2643.31 | 2784.59 | 2951.72 | 3152.60 |
| 9.40% | 2220.90 | 2306.86 | 2405.03 | 2518.29 | 2650.47 |
| 10.40% | 1987.19 | 2050.36 | 2121.34 | 2201.69 | 2293.46 |
| 11.40% | 1800.63 | 1848.33 | 1901.21 | 1960.22 | 2026.51 |
Outlined: this model. Green text: above today's price of 13.03. Shading: distance from this model's own value.
Priced In
What each input would have to be to justify the current price, one at a time.
| Input | Model | Implied | Gap |
|---|---|---|---|
| EBIT margin | 31.8% | -7.5% | -39.3pp |
Live formulas, not pasted numbers - edit a driver and the workbook reprices.
Yahoo Finance and RBA data. General information, not advice. Methodology.